Published online Nov 8, 2016. doi: 10.5409/wjcp.v5.i4.391
Peer-review started: May 30, 2016
First decision: July 6, 2016
Revised: August 16, 2016
Accepted: August 27, 2016
Article in press: August 29, 2016
Published online: November 8, 2016
To summarize the reported Middle East respiratory syndrome-coronavirus (MERS-CoV) cases, the associated clinical presentations and the outcomes.
We searched the Saudi Ministry of Health website, the World Health Organization website, and the Flutracker website. We also searched MEDLINE and PubMed for the keywords: Middle East respiratory syndrome-coronavirus, MERS-CoV in combination with pediatric, children, childhood, infancy and pregnancy from the initial discovery of the virus in 2012 to 2016. The retrieved articles were also read to further find other articles. Relevant data were placed into an excel sheet and analyzed accordingly. Descriptive analytic statistics were used in the final analysis as deemed necessary.
From June 2012 to April 19, 2016, there were a total of 31 pediatric MERS-CoV cases. Of these cases 13 (42%) were asymptomatic and the male to female ratio was 1.7:1. The mean age of patients was 9.8 ± 5.4 years. Twenty-five (80.6%) of the cases were reported from the Kingdom of Saudi Arabia. The most common source of infection was household contact (10 of 15 with reported source) and 5 patients acquired infection within a health care facility. Using real time reverse transcriptase polymerase chain reaction of pediatric patients revealed that 9 out of 552 (1.6%) was positive in the Kingdom of Saudi Arabia.
Utilizing serology for MERS-CoV infection in Jordan and Saudi Arabia did not reveal any positive patients. Thus, the number of the pediatric MERS-CoV is low; the exact reason for the low prevalence of the disease in children is not known.
Core tip: The number of the pediatric Middle East respiratory syndrome-coronavirus (MERS-CoV) is low and the exact reason for the low prevalence is not known. A total of 31 pediatric MERS-CoV cases were reported since June 2012. Of all the cases 13 (42%) were asymptomatic and the male to female ratio was 1.7:1. The mean age of patients was 9.8 ± 5.4 years.The most common source of infection was household contact followed by infection within a health care facility. Using real time reverse transcriptase polymerase chain reaction of pediatric patients revealed that 9 out of 552 (1.6%) was positive in the Kingdom of Saudi Arabia.
- Citation: Al-Tawfiq JA, Kattan RF, Memish ZA. Middle East respiratory syndrome coronavirus disease is rare in children: An update from Saudi Arabia. World J Clin Pediatr 2016; 5(4): 391-396
- URL: https://www.wjgnet.com/2219-2808/full/v5/i4/391.htm
- DOI: https://dx.doi.org/10.5409/wjcp.v5.i4.391
Middle East respiratory syndrome-coronavirus (MERS-CoV) was first isolated in 2012 from a patient in the Kingdom of Saudi Arabia (KSA)[1]. As more cases were reported, the case fatality rate changed to 40% from 60%[2-5]. In addition, initially there was a predominance of males; later this ratio decreased[2,6]. MERS-CoV is characterized by three different patterns of disease: Sporadic cases, intra-familial transmission[7-9] and health care associated infection[2,3,10-16]. Despite the increased number overtime and the multiple health care associated outbreaks[17], the number of pediatric cases remained low during the study period[18]. The initial description of 47 cases included only a 14-year-old child[4]. The first pediatric case was a 2-year-old child reported from Jeddah, KSA on June 28, 2013[19]. Later an additional three asymptomatic children were reported[4]. The largest report of childhood MERS-CoV cases included eleven, of which two patients were symptomatic and nine were asymptomatic[18]. The exact reason for this low prevalence of the disease in children is not known. In this study, we summarize the reported MERS-CoV cases and the associated clinical presentation and the outcome.
We searched the Saudi Ministry of Health website[20], the World Health Organization website[21], the Flutracker website[22], the medical literature and the retrieved published studies for any childhood MERS-CoV infections. We searched MEDLINE and PubMed for the keywords Middle East respiratory syndrome-coronavirus, MERS-CoV, in combination with pediatric, children, childhood, infancy and pregnancy from the initial discovery of the virus in June 2012 until April 19, 2016. The retrieved articles were also read to find other relevant articles.
Relevant data were placed into an excel sheet and analyzed accordingly. Descriptive analytic statistics were used in the final analysis as deemed necessary, including mean and standard deviation when applicable and frequency. The statistical review of the study was performed by a biomedical statistician. Statistical review is performed before the submission of the manuscript.
From June 2012, to April 19, 2016, there were a total of 31 pediatric MERS-CoV cases as shown in Table 1. Of all the cases, thirteen (13) or 42% were asymptomatic, and there were 17 males, 10 females and 4 unreported (a male to female ratio of 1.7:1). The mean age of patients was 9.8 + 5.4 (0.75-17) years. Twenty-five cases (80.6%) were reported from KSA; the other patients were in Jordan, United Arab Emirates and the Republic of Korea (Table 1). The most common source of the infection was household contact (10 of 15 with reported source), and 5 patients acquired the infection within a health care facility. About one half of the cases were reported in 2014, and 29% were reported in 2013 and 22.6% in 2015 (Table 2).
| Age | Gender | Country | Sample source | Year of reporting | Symptoms | Co-morbidity | Signs | Sample type | Viral load ct value | Imaging | Intensive care | Death | Ref. |
| 2 | Male | KSA | Hospital inpatient | 2013 | Fever, respiratory distress | Cystic fibrosis | Chest: Bilateral fine crepitation | NPS | 36 | Bilateral diffused infiltrate | + | Yes | [18] |
| 14 | Female | KSA | Hospital inpatient | 2013 | Fever | Down’s syndrome | NPS | 37 | Bilateral diffused infiltrate | No | No | [18] | |
| 7 | Female | KSA | Family contact | 2013 | Asymptomatic | None | None | N + T | 37 | ND | No | No | [18] |
| 15 | Female | KSA | Family contact | 2014 | Asymptomatic | None | None | NPS | 35 | ND | No | No | [18] |
| 14 | Male | KSA | Family contact | 2014 | Asymptomatic | None | None | NPS | 34 | ND | No | No | [18] |
| 12 | Female | KSA | Family contact | 2014 | Asymptomatic | None | None | NPS | 35 | ND | No | No | [18] |
| 16 | male | KSA | Family contact | 2013 | Asymptomatic | None | none | NPS | 36 | ND | No | No | [18] |
| 7 | Female | KSA | Family contact | 2014 | Asymptomatic | None | none | NPS | 37 | ND | No | No | [18] |
| 3 | Female | KSA | Family contact | 2013 | Asymptomatic | None | none | NPS | 38 | ND | No | No | [18] |
| 13 | Female | KSA | Contact | 2014 | Asymptomatic | None | none | NPS | 34 | ND | No | No | [18] |
| 14 | Female | KSA | Family contact | 2013 | Asymptomatic | None | none | NPS | 36 | ND | No | No | [18] |
| 0.75 | Male | KSA | Not known | 2014 | ICU | Nephrotic syndrome | Respiratory distress | Tracheal aspirate | NA | Diffuse bilateral haziness | Yes | Yes | [35] |
| 4 | Male | KSA | NA | 2013 | Mild respiratory symptoms | None | NA | NA | ND | No | No | [36] | |
| 8 | Male | KSA | NA | 2013 | Mild respiratory symptoms | None | NA | NA | ND | NA | No | [37] | |
| 17 | NA | KSA | Contact | 2014 | Asymptomatic | NA | NA | NA | NA | NA | NA | NA | [22] |
| 11 | NA | KSA | Contact | 2014 | Asymptomatic | NA | NA | NA | NA | NA | NA | NA | [22] |
| 16 | NA | KSA | NA | 2014 | Symptomatic | NA | NA | NA | NA | NA | NA | NA | [22] |
| 13 | M | KSA | NA | 2014 | Symptomatic | NA | NA | NA | NA | NA | NA | NA | [22] |
| 10 | M | KSA | Hospital contact | 2014 | Symptomatic | NA | NA | NA | NA | NA | NA | NA | [20,22] |
| 2 | NA | KSA | NA | 2014 | Symptomatic | Congenital anomalies | NA | NA | NA | NA | NA | NA | [20,22] |
| 11 | M | KSA | Hospital contact | 2014 | Symptomatic | Brain tumor | NA | NA | NA | NA | NA | NA | [20,22] |
| 17 | M | KSA | NA | 2014 | Symptomatic | NA | NA | NA | NA | NA | NA | NA | [20,22] |
| 16 | M | South Korea | Hospital contact | 2015 | Symptomatic | NA | NA | NA | NA | NA | NA | NA | [22] |
| 2 | M | KSA | Hospital contact | 2015 | Symptomatic | NA | NA | NA | NA | NA | NA | NA | [20,22] |
| 16 | M | KSA | contact | 2015 | Symptomatic | NA | NA | NA | NA | NA | NA | NA | [20,22] |
| 7 | F | Jordan | Contact | 2015 | Asymptomatic | None | NA | NA | NA | NA | NA | NA | [22] |
| 0.8 | F | Jordan | Contact | 2015 | Symptomatic | None | NA | NA | NA | NA | NA | NA | [22] |
| 14 | M | KSA | Contact | 2015 | Symptomatic | None | NA | NA | NA | NA | NA | NA | [20,22] |
| 4 | M | UAE | NA | 2014 | NA | NA | NA | NA | NA | NA | NA | NA | [22] |
| 8 | M | UAE | Family contact | 2013 | NA | NA | NA | NA | NA | NA | NA | NA | [22] |
| 11 | M | UAE | Family contact | 2015 | Asymptomatic | None | NA | NA | NA | NA | NA | NA | [22] |
| No. | % | |
| Male:female | 17:10 (1.7:1) | 63 vs 37 |
| Saudi | 20 | 83.3 |
| City | ||
| Jeddah | 7 | 29.2 |
| Riyadh | 7 | 29.2 |
| Hafr al-Batin | 3 | 12.5 |
| Symptomatic | 12 | 50.0 |
| Death | 8 | 33.3 |
| Year of report | ||
| 2013 | 9 | 29 |
| 2014 | 15 | 48.4 |
| 2015 | 7 | 22.6 |
Screening of pediatric patients for MERS-CoV infection using real time reverse transcriptase polymerase chain reaction showed that only 9 out of 552 (1.6%) were positive in KSA[23]. However, serologic testing of pediatric patients admitted with lower respiratory tract infection in Jordan and Saudi Arabia revealed no positive tests[24,25] (Table 3).
| Country | Testing method | Population | Positive n (%) | Yr | Ref. |
| KSA | rRT-PCR | Screening of children | 9/552 (1.6) | [23] | |
| KSA | Neutralizing antibodies testing | Serum samples from children hospitalized for lower respiratory tract infections | 0/158 (0) | May 2010-May 2011 | [25] |
| Jordan | rRT-PCR | Hospitalized children < 2 yr of age | 0/2427 (0) | [24] |
The effect of MERS-CoV infection on the fetus was described in eight cases[26-29] as summarized in Table 4. The mean age of the mothers was 32.25 + 3.4 years, and the mean gestational age was 28.4 + 6.3 wk. Death of the fetus was observed in 3 (37.5%) of the 8 fetuses.
| Age of the patient (yr) | Gestational age | Fetal outcome | Diagnostic test | Country | Ref. |
| 39 | 5 mo | Still birth | Antibody by EIA | Jordan | [26] |
| 33 | 32 wk | Healthy infant | PCR | Saudi Arabia | [27] |
| 32 | 32 wk | Healthy | PCR | United Arab Emirates | [28] |
| 34 | 34 wk | Died | PCR | Saudi Arabia | [29] |
| 32 | 38 wk | Survived | PCR | Saudi Arabia | [29] |
| 31 | 24 wk | Died | PCR | Saudi Arabia | [29] |
| 27 | 22 wk | Survived | PCR | Saudi Arabia | [29] |
| 30 | 23 wk | Survived | PCR | Saudi Arabia | [29] |
Despite the total number of MERS cases increasing, especially in KSA, the number of pediatric cases remained low during the study period. Initially, the testing in KSA was directed towards hospitalized patients with severe pneumonia. In 2015, the Saudi Ministry of Health added a specific case definition for MERS-CoV infection in children[30]. The definition includes those ≤ 14 years, meets the adult case definition and has either a history of exposure to a confirmed or suspected MERS-CoV in the proceeding 14 d or a history of contact with camels or camel products in the proceeding 14 d[30]. The case definition also includes children with unexplained severe pneumonia[30]. The 2015 change in the case definition does not account for the low rate of childhood MERS-CoV infection as 33% of the cases were reported in 2014 before the case definition was changed. One of the reasons for an increased number of cases in 2014 during the Jeddah outbreak was increased testing of asymptomatic and mildly symptomatic patients[11].
The pattern of MERS-CoV pediatric cases was similar to the 2003 SARS outbreak. Children were less affected than adults and children less than 2 years of age had milder disease[31]. In the largest screening of contacts, the rate of MERS-CoV positive children (1.6%, 9/616) compared to 2.2% (99/4440) in adults (P = 0.23)[23]. Thus, in this study utilizing MERS-CoV PCR the positivity rate did not differ in children and adults.
In adults with MERS-CoV infections, three patterns of transmissions were observed: Sporadic (primary) cases presumed to be due to animal exposure (mainly camels), household contacts or health care associated infections[32]. In KSA, the majority (45%) of cases were health care-associated infections, 38% were primary cases, and 13% were household contacts[32]. In contrast, in the majority of pediatric cases that reported source of acquisition (66.7% of the 15 with reported source), the disease was acquired through household contact. This pattern indicates a low exposure of children to animals and a higher rate of health care associated infections in adult wards. The male to female ratio (2.8:1 and 3.3:1) was initially high[3,4]. This apparent male predominance could be explained by the nature of hospital outbreaks[2]. Eventually the male to female ratio was reduced to 1.3:1 to 1.8:1[5,6]. Consistent with these studies, the male to female ratio in children with MERS-CoV was 1.7:1 and may indicate similar exposure of children to index cases in the household settings and differential host factors.
Possible explanations for the lower number of pediatric cases compared to adults include differential testing of adult patients and milder diseases in children; although, serologic testing of pediatric patients in KSA and Jordan did not reveal any positive cases[24,25]. In the largest sero-epidemiologic survey in KSA, the study did not include children and thus it is difficult to establish the rate of sero-positivity in children[31].
The MERS-CoV infection rate in children remains low and possible explanations include: A milder disease in children, asymptomatic infection, or the presence of yet to be identified factors. The development of a shorter duration of MERS in children is another possible explanation. If this is the case, it may limit the development of a positive serology. In one study, delayed antibody responses as measured with the neutralization test was associated with severe diseases[33]. The longevity of antibodies in MERS-CoV cases might be limited as was the case with SARS[33,34]. The only study of serology among children was done among hospitalized pediatric cases who presented with lower respiratory tract infections[25]. There is no systematic screening of exposed children using serologic testing; this limited the interpretation of available serologic studies.
Little data also exist regarding the effect and the likelihood of MERS-CoV in pregnancy. Eight cases were reported[26,27,29]. The outcome was favorable in the majority of cases. The exact prevalence of MERS-CoV antibodies and exposure of pregnant women to MERS-CoV is not known.
In conclusion, the number of MERS-CoV infections in pediatric patients remains low. Possible explanations include low exposure, presence of asymptomatic, mildly symptomatic patients or the presence of yet to be identified factors. The immune system predisposing to severe disease and to fatal outcome remains unknown. An exploration of the virus-host interaction may add to the understanding of the low prevalence in this age group.
Middle East respiratory syndrome-coronavirus (MERS-CoV) was first isolated in 2012 from a patient in the Kingdom of Saudi Arabia (KSA). Despite the increased number of MERS-CoV cases overtime, the number of pediatric cases remained low. The exact reason for this low prevalence of the disease in children is not known. The aim of this study is to summarize the reported MERS-CoV cases and the associated clinical presentation and the outcome.
The first pediatric case was a two-year-old child reported from Jeddah, KSA on June 28, 2013. Later an additional three asymptomatic children were reported. The largest report of childhood MERS-CoV cases included eleven, including nine asymptomatic cases.
The number of MERS-CoV infections in pediatric patients remains low. Possible explanations include low exposure, presence of asymptomatic, mildly symptomatic patients or the presence of yet to be identified factors. The immune system predisposing to severe disease and to fatal outcome remains unknown. An exploration of the virus-host interaction may add to the understanding of the low prevalence in this age group.
Despite the low number of pediatric MERS-CoV cases, it is important to continue to monitor the development of this disease in this age group and to understand the risk factors.
MERS-CoV is a new emerging virus that was first isolated in 2012.
This complication of all known pediatric cases is a useful contribution to the medical literature, and knowing it is possible but rare is important.
Manuscript source: Invited manuscript
Specialty type: Pediatrics
Country of origin: Kingdom of Saudi Arabia
Peer-review report classification
Grade A (Excellent): 0
Grade B (Very good): 0
Grade C (Good): C, C
Grade D (Fair): 0
Grade E (Poor): 0
P- Reviewer: Chen XL, Striker R S- Editor: Ji FF L- Editor: A E- Editor: Li D
| 1. | Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367:1814-1820. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 4030] [Cited by in F6Publishing: 3819] [Article Influence: 318.3] [Reference Citation Analysis (0)] |
| 2. | Al-Tawfiq JA, Memish ZA. Middle East respiratory syndrome coronavirus: epidemiology and disease control measures. Infect Drug Resist. 2014;7:281-287. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 14] [Cited by in F6Publishing: 46] [Article Influence: 4.6] [Reference Citation Analysis (0)] |
| 3. | Assiri A, McGeer A, Perl TM, Price CS, Al Rabeeah AA, Cummings DA, Alabdullatif ZN, Assad M, Almulhim A, Makhdoom H. Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med. 2013;369:407-416. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 888] [Cited by in F6Publishing: 888] [Article Influence: 80.7] [Reference Citation Analysis (0)] |
| 4. | Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, Al-Rabiah FA, Al-Hajjar S, Al-Barrak A, Flemban H, Al-Nassir WN, Balkhy HH, Al-Hakeem RF. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis. 2013;13:752-761. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 969] [Cited by in F6Publishing: 1006] [Article Influence: 91.5] [Reference Citation Analysis (0)] |
| 5. | Penttinen PM, Kaasik-Aaslav K, Friaux A, Donachie A, Sudre B, Amato-Gauci AJ, Memish ZA, Coulombier D. Taking stock of the first 133 MERS coronavirus cases globally--Is the epidemic changing? Euro Surveill. 2013;18:pii: 20596. [PubMed] [Cited in This Article: ] |
| 6. | The WHO Mers-Cov Research Group. State of Knowledge and Data Gaps of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Humans. PLoS Curr. 2013;5. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 87] [Cited by in F6Publishing: 230] [Article Influence: 20.9] [Reference Citation Analysis (0)] |
| 7. | Memish ZA, Zumla AI, Al-Hakeem RF, Al-Rabeeah AA, Stephens GM. Family cluster of Middle East respiratory syndrome coronavirus infections. N Engl J Med. 2013;368:2487-2494. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 333] [Cited by in F6Publishing: 346] [Article Influence: 31.5] [Reference Citation Analysis (0)] |
| 8. | Omrani AS, Matin MA, Haddad Q, Al-Nakhli D, Memish ZA, Albarrak AM. A family cluster of Middle East Respiratory Syndrome Coronavirus infections related to a likely unrecognized asymptomatic or mild case. Int J Infect Dis. 2013;17:e668-e672. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 125] [Cited by in F6Publishing: 131] [Article Influence: 11.9] [Reference Citation Analysis (0)] |
| 9. | Memish ZA, Cotten M, Watson SJ, Kellam P, Zumla A, Alhakeem RF, Assiri A, Rabeeah AA, Al-Tawfiq JA. Community case clusters of Middle East respiratory syndrome coronavirus in Hafr Al-Batin, Kingdom of Saudi Arabia: a descriptive genomic study. Int J Infect Dis. 2014;23:63-68. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 65] [Cited by in F6Publishing: 71] [Article Influence: 7.1] [Reference Citation Analysis (0)] |
| 10. | Oboho IK, Tomczyk SM, Al-Asmari AM, Banjar AA, Al-Mugti H, Aloraini MS, Alkhaldi KZ, Almohammadi EL, Alraddadi BM, Gerber SI. 2014 MERS-CoV outbreak in Jeddah--a link to health care facilities. N Engl J Med. 2015;372:846-854. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 340] [Cited by in F6Publishing: 341] [Article Influence: 37.9] [Reference Citation Analysis (0)] |
| 11. | Drosten C, Muth D, Corman VM, Hussain R, Al Masri M, HajOmar W, Landt O, Assiri A, Eckerle I, Al Shangiti A. An observational, laboratory-based study of outbreaks of middle East respiratory syndrome coronavirus in Jeddah and Riyadh, kingdom of Saudi Arabia, 2014. Clin Infect Dis. 2015;60:369-377. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 133] [Cited by in F6Publishing: 142] [Article Influence: 14.2] [Reference Citation Analysis (0)] |
| 12. | Al-Tawfiq JA, Memish ZA. An update on Middle East respiratory syndrome: 2 years later. Expert Rev Respir Med. 2015;9:327-335. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis (0)] |
| 13. | Al-Tawfiq JA, Memish ZA. Middle East respiratory syndrome coronavirus: transmission and phylogenetic evolution. Trends Microbiol. 2014;22:573-579. [PubMed] [Cited in This Article: ] |
| 14. | Hijawi B, Abdallat M, Sayaydeh A, Alqasrawi S, Haddadin A, Jaarour N, Alsheikh S, Alsanouri T. Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation. East Mediterr Health J. 2013;19 Suppl 1:S12-S18. [PubMed] [Cited in This Article: ] |
| 15. | Kim Y, Lee S, Chu C, Choe S, Hong S, Shin Y. The Characteristics of Middle Eastern Respiratory Syndrome Coronavirus Transmission Dynamics in South Korea. Osong Public Health Res Perspect. 2016;7:49-55. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 69] [Cited by in F6Publishing: 71] [Article Influence: 8.9] [Reference Citation Analysis (0)] |
| 16. | Seong MW, Kim SY, Corman VM, Kim TS, Cho SI, Kim MJ, Lee SJ, Lee JS, Seo SH, Ahn JS. Microevolution of Outbreak-Associated Middle East Respiratory Syndrome Coronavirus, South Korea, 2015. Emerg Infect Dis. 2016;22:327-330. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 25] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis (0)] |
| 17. | Al-Tawfiq JA, Memish ZA. Managing MERS-CoV in the healthcare setting. Hosp Pract (1995). 2015;43:158-163. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis (0)] |
| 18. | Memish ZA, Al-Tawfiq JA, Assiri A, AlRabiah FA, Al Hajjar S, Albarrak A, Flemban H, Alhakeem RF, Makhdoom HQ, Alsubaie S. Middle East respiratory syndrome coronavirus disease in children. Pediatr Infect Dis J. 2014;33:904-906. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 114] [Cited by in F6Publishing: 119] [Article Influence: 11.9] [Reference Citation Analysis (0)] |
| 19. | WHO. MERS-CoV summary and literature. [update 2013 Jun 20]. Available from: http://www.who.int/csr/disease/coronavirus_infections/update_20130620/en/. [Cited in This Article: ] |
| 20. | Saudi Ministry of Health C and CC. MERS-CoV Statistics. Available from: http://www.moh.gov.sa/en/ccc/pressreleases/pages/default.aspx. [Cited in This Article: ] |
| 21. | WHO. Middle East respiratory syndrome coronavirus (MERS-CoV). Available from: http://www.who.int/emergencies/mers-cov/en/. [Cited in This Article: ] |
| 22. | Flutracker. 2012-2016 Case List of MoH/WHO Novel Coronavirus MERS nCoV Announced Cases. Available from: https://flutrackers.com/forum/forum/novel-coronavirus-ncov-mers-2012-2014/146270-2012-2016-case-list-of-moh-who-novel-coronavirus-mers-ncov-announced-cases. [Cited in This Article: ] |
| 23. | Memish ZA, Al-Tawfiq JA, Makhdoom HQ, Al-Rabeeah AA, Assiri A, Alhakeem RF, AlRabiah FA, Al Hajjar S, Albarrak A, Flemban H. Screening for Middle East respiratory syndrome coronavirus infection in hospital patients and their healthcare worker and family contacts: a prospective descriptive study. Clin Microbiol Infect. 2014;20:469-474. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 95] [Cited by in F6Publishing: 104] [Article Influence: 10.4] [Reference Citation Analysis (0)] |
| 24. | Khuri-Bulos N, Payne DC, Lu X, Erdman D, Wang L, Faouri S, Shehabi A, Johnson M, Becker MM, Denison MR. Middle East respiratory syndrome coronavirus not detected in children hospitalized with acute respiratory illness in Amman, Jordan, March 2010 to September 2012. Clin Microbiol Infect. 2014;20:678-682. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 11] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis (0)] |
| 25. | Gierer S, Hofmann-Winkler H, Albuali WH, Bertram S, Al-Rubaish AM, Yousef AA, Al-Nafaie AN, Al-Ali AK, Obeid OE, Alkharsah KR. Lack of MERS coronavirus neutralizing antibodies in humans, eastern province, Saudi Arabia. Emerg Infect Dis. 2013;19:2034-2036. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 4.2] [Reference Citation Analysis (0)] |
| 26. | Payne DC, Iblan I, Alqasrawi S, Al Nsour M, Rha B, Tohme RA, Abedi GR, Farag NH, Haddadin A, Al Sanhouri T. Stillbirth during infection with Middle East respiratory syndrome coronavirus. J Infect Dis. 2014;209:1870-1872. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 78] [Cited by in F6Publishing: 79] [Article Influence: 7.9] [Reference Citation Analysis (0)] |
| 27. | Alserehi H, Wali G, Alshukairi A, Alraddadi B. Impact of Middle East Respiratory Syndrome coronavirus (MERS-CoV) on pregnancy and perinatal outcome. BMC Infect Dis. 2016;16:105. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 120] [Cited by in F6Publishing: 117] [Article Influence: 14.6] [Reference Citation Analysis (0)] |
| 28. | Malik A, El Masry KM, Ravi M, Sayed F. Middle East Respiratory Syndrome Coronavirus during Pregnancy, Abu Dhabi, United Arab Emirates, 2013. Emerg Infect Dis. 2016;22:515-517. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 58] [Cited by in F6Publishing: 63] [Article Influence: 7.9] [Reference Citation Analysis (0)] |
| 29. | Assiri A, Abedi GR, Almasry M, Bin Saeed A, Gerber SI, Watson JT. Middle East Respiratory Syndrome Coronavirus Infection During Pregnancy: A Report of 5 Cases From Saudi Arabia. Clin Infect Dis. 2016;63:951-953. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 113] [Cited by in F6Publishing: 117] [Article Influence: 14.6] [Reference Citation Analysis (0)] |
| 30. | Madani TA, Althaqafi AO, Alraddadi BM. Infection prevention and control guidelines for patients with Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection. Saudi Med J. 2014;35:897-913. [PubMed] [Cited in This Article: ] |
| 31. | Denison MR. Severe acute respiratory syndrome coronavirus pathogenesis, disease and vaccines: an update. Pediatr Infect Dis J. 2004;23:S207-S214. [PubMed] [Cited in This Article: ] |
| 32. | Al-Tawfiq JA, Memish ZA. Drivers of MERS-CoV transmission: what do we know? Expert Rev Respir Med. 2016;10:331-338. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis (0)] |
| 33. | Park WB, Perera RA, Choe PG, Lau EH, Choi SJ, Chun JY, Oh HS, Song KH, Bang JH, Kim ES. Kinetics of Serologic Responses to MERS Coronavirus Infection in Humans, South Korea. Emerg Infect Dis. 2015;21:2186-2189. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 117] [Cited by in F6Publishing: 121] [Article Influence: 15.1] [Reference Citation Analysis (0)] |
| 34. | Cao WC, Liu W, Zhang PH, Zhang F, Richardus JH. Disappearance of antibodies to SARS-associated coronavirus after recovery. N Engl J Med. 2007;357:1162-1163. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 313] [Cited by in F6Publishing: 277] [Article Influence: 16.3] [Reference Citation Analysis (0)] |
| 35. | Thabet F, Chehab M, Bafaqih H, Al Mohaimeed S. Middle East respiratory syndrome coronavirus in children. Saudi Med J. 2015;36:484-486. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 77] [Cited by in F6Publishing: 82] [Article Influence: 10.3] [Reference Citation Analysis (0)] |
| 36. | WHO. Middle East respiratory syndrome coronavirus (MERS-CoV) update. Disease Outbreak News. [updated 2014 Apr 26]. Available from: http://www.who.int/csr/don/2014_04_26_mers/en/. [Cited in This Article: ] |
| 37. | WHO. Middle East respiratory syndrome coronavirus (MERS-CoV) update. Disease Outbreak News. [updated 2013 Dec 2]. Available from: http://www.who.int/csr/don/2013_12_02/en/. [Cited in This Article: ] |